Patient-Specific Immunotherapy Shows Promise in HIV Studies

New data from clinical studies of AG-S004 , a patient-specific immunotherapy currently in development for the treatment of human immunodeficiency virus infection, were presented March 4 at the Conference on Retroviruses and Opportunistic Infections meeting in Boston.

http://ift.tt/1eZj3mP